Morgan Stanley 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-10 4:04 pm Sale | 2021-04-30 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 399,919 1.400% | -1,781,699 (-81.67%) | Filing |
| 2021-02-11 2:11 pm Purchase | 2020-12-31 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 2,181,618 7.900% | 302,638 (+16.11%) | Filing |
| 2020-10-26 4:02 pm Purchase | 2020-10-15 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 1,878,980 6.800% | 1,878,980 (New Position) | Filing |